MedTrace Logo

Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study

NCT02939378 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-10-20

No results posted yet for this study

Summary

Recently, ketogenic diet has been recognized a useful treatment strategy for glioblastoma in vitro.

Therefore, the purpose of the study is to evaluate the safety and efficacy of ketogenic adjuvant to salvage chemotherapy for recurrent glioblastoma.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ketogenic diet

Ketogenic diet adjuvant to salvage chemotherapy is given to recurrent glioblastomas.

DIETARY_SUPPLEMENT

Standard diet

Standard diet adjuvant to salvage chemotherapy is given to recurrent glioblastomas.

Sponsors & Collaborators

  • Song Lin

    lead OTHER

Principal Investigators

  • Song Lin, M.D., · Beijing Tiantan Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02939378 on ClinicalTrials.gov